Progress on Breast Cancer Hasn’t Been Evenly Distributed. This Funder’s on the Case

Progress on Breast Cancer Hasn’t Been Evenly Distributed. This Funder’s on the Case

Tackling demographic disparities in outcomes and care has been a big priority for cancer funders lately. Susan G. Komen, a major backer of breast cancer research, care and advocacy, is no exception.

Read More

Does Komen Need a Cure of its Own?

Does Komen Need a Cure of its Own?

Susan G. Komen is a fundraising powerhouse, successful in part by talking up its quest “for the cure.” But an L.A. business professor says Komen's research funding is a fraction of what it could be—and it’s not being transparent about its spending.

Read More

Path to Recovery: The Latest From a Leader in Breast Cancer Research Funding

Path to Recovery: The Latest From a Leader in Breast Cancer Research Funding

Susan G. Komen recently announced grants of $26 million to fund 62 new research projects that address some of the most difficult breast cancer cases. After years of troubles, this important funder has bounced back in a big way.

Read More